(Q34647014)

3 August 2017

Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease (English)

1 reference

3 August 2017

anti-retroviral agent

0 references

author

Jane Anderson

13

1 reference

3 August 2017

K Porter

5

0 references

Caroline Sabin

21

object named as

C A Sabin

1 reference

3 August 2017

L Garvey

1

1 reference

3 August 2017

A Winston

2

1 reference

3 August 2017

J Walsh

3

1 reference

3 August 2017

F Post

4

1 reference

3 August 2017

B Gazzard

6

1 reference

3 August 2017

M Fisher

7

1 reference

3 August 2017

C Leen

8

1 reference

3 August 2017

D Pillay

9

1 reference

3 August 2017

T Hill

10

1 reference

3 August 2017

M Johnson

11

1 reference

3 August 2017

R Gilson

12

1 reference

3 August 2017

P Easterbrook

14

1 reference

3 August 2017

L Bansi

15

1 reference

3 August 2017

C Orkin

16

1 reference

3 August 2017

J Ainsworth

17

1 reference

3 August 2017

A Palfreeman

18

1 reference

3 August 2017

M Gompels

19

1 reference

3 August 2017

A N Phillips

20

1 reference

3 August 2017

UK Collaborative HIV Cohort (CHIC) study

22

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

3 August 2017

1 reference

3 August 2017

76

1 reference

3 August 2017

8

1 reference

3 August 2017

693-700

1 reference

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Changing incidence of central nervous system diseases in the EuroSIDA cohort

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3053326

The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21339496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21339496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0B013E31820D8B0B

1 reference

3 August 2017

1 reference

3 August 2017

1 reference